Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-26-010344
Filing Date
2026-01-12
Accepted
2026-01-12 16:01:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 6575
  Complete submission text file 0001193125-26-010344.txt   8437
Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Subject) CIK: 0001800315 (see all company filings)

EIN.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91812 | Film No.: 26526669
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FAIRMOUNT FUNDS MANAGEMENT, LLC 2001 MARKET STREET, SUITE 2500 PHILADELPHIA PA 19103
Business Address C/O FAIRMOUNT FUNDS MANAGEMENT, LLC 2001 MARKET STREET, SUITE 2500 PHILADELPHIA PA 19103 (267) 760-4066
Paragon Therapeutics, Inc. (Filed by) CIK: 0001861055 (see all company filings)

EIN.: 862707757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G